← brief for 2026-10-20 · Slowing decline

Finerenone: A Non-Steroidal Mineralocorticoid Receptor Antagonist and Its Emerging Role in Cardiovascular-Kidney-Metabolic Syndrome.

Article No results yet Peer reviewed

Key takeaways

This article explains how finerenone works to protect the heart and kidneys. It blocks a hormone receptor that causes inflammation and scarring. The text reviews large studies but does not report new trial results of its own.

Who did this work

Fischer KG · Beavers CJ

Source

Article · PubMed, the drug frontier · 2026 Oct 20
https://pubmed.ncbi.nlm.nih.gov/42900175/